These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Inhibition of pluripotent stem cell-derived teratoma formation by small molecules. Lee MO; Moon SH; Jeong HC; Yi JY; Lee TH; Shim SH; Rhee YH; Lee SH; Oh SJ; Lee MY; Han MJ; Cho YS; Chung HM; Kim KS; Cha HJ Proc Natl Acad Sci U S A; 2013 Aug; 110(35):E3281-90. PubMed ID: 23918355 [TBL] [Abstract][Full Text] [Related]
3. Modulation of Wnt/BMP pathways during corneal differentiation of hPSC maintains ABCG2-positive LSC population that demonstrates increased regenerative potential. Vattulainen M; Ilmarinen T; Koivusalo L; Viiri K; Hongisto H; Skottman H Stem Cell Res Ther; 2019 Aug; 10(1):236. PubMed ID: 31383008 [TBL] [Abstract][Full Text] [Related]
4. A massive suspension culture system with metabolic purification for human pluripotent stem cell-derived cardiomyocytes. Hemmi N; Tohyama S; Nakajima K; Kanazawa H; Suzuki T; Hattori F; Seki T; Kishino Y; Hirano A; Okada M; Tabei R; Ohno R; Fujita C; Haruna T; Yuasa S; Sano M; Fujita J; Fukuda K Stem Cells Transl Med; 2014 Dec; 3(12):1473-83. PubMed ID: 25355733 [TBL] [Abstract][Full Text] [Related]
5. Novel surface-enhanced Raman scattering-based assays for ultra-sensitive detection of human pluripotent stem cells. Han J; Qian X; Wu Q; Jha R; Duan J; Yang Z; Maher KO; Nie S; Xu C Biomaterials; 2016 Oct; 105():66-76. PubMed ID: 27509304 [TBL] [Abstract][Full Text] [Related]
6. Integrated platform for production and purification of human pluripotent stem cell-derived neural precursors. Rodrigues GM; Matos AF; Fernandes TG; Rodrigues CA; Peitz M; Haupt S; Diogo MM; Brüstle O; Cabral JM Stem Cell Rev Rep; 2014 Apr; 10(2):151-61. PubMed ID: 24221956 [TBL] [Abstract][Full Text] [Related]
7. An antibody against SSEA-5 glycan on human pluripotent stem cells enables removal of teratoma-forming cells. Tang C; Lee AS; Volkmer JP; Sahoo D; Nag D; Mosley AR; Inlay MA; Ardehali R; Chavez SL; Pera RR; Behr B; Wu JC; Weissman IL; Drukker M Nat Biotechnol; 2011 Aug; 29(9):829-34. PubMed ID: 21841799 [TBL] [Abstract][Full Text] [Related]
8. The telomerase inhibitor AZT enhances differentiation and prevents overgrowth of human pluripotent stem cell-derived neural progenitors. Hu Y; Fang KH; Shen LP; Cao SY; Yuan F; Su Y; Xu M; Pan Y; Chen Y; Liu Y J Biol Chem; 2018 Jun; 293(23):8722-8733. PubMed ID: 29628445 [TBL] [Abstract][Full Text] [Related]
9. Application of human pluripotent stem cells and pluripotent stem cell-derived cellular models for assessing drug toxicity. Apáti Á; Varga N; Berecz T; Erdei Z; Homolya L; Sarkadi B Expert Opin Drug Metab Toxicol; 2019 Jan; 15(1):61-75. PubMed ID: 30526128 [No Abstract] [Full Text] [Related]
10. Assessing Cell Competition in Human Pluripotent Stem Cell (hPSC) Cultures. Price CJ; Barbaric I Curr Protoc; 2022 May; 2(5):e435. PubMed ID: 35621694 [TBL] [Abstract][Full Text] [Related]
11. Enhanced Therapeutic and Long-Term Dynamic Vascularization Effects of Human Pluripotent Stem Cell-Derived Endothelial Cells Encapsulated in a Nanomatrix Gel. Lee SJ; Sohn YD; Andukuri A; Kim S; Byun J; Han JW; Park IH; Jun HW; Yoon YS Circulation; 2017 Nov; 136(20):1939-1954. PubMed ID: 28972000 [TBL] [Abstract][Full Text] [Related]
12. The combination of dextran sulphate and polyvinyl alcohol prevents excess aggregation and promotes proliferation of pluripotent stem cells in suspension culture. Tang X; Wu H; Xie J; Wang N; Chen Q; Zhong Z; Qiu Y; Wang J; Li X; Situ P; Lai L; Zern MA; Chen H; Duan Y Cell Prolif; 2021 Sep; 54(9):e13112. PubMed ID: 34390064 [TBL] [Abstract][Full Text] [Related]
13. Improving the safety of human pluripotent stem cell therapies using genome-edited orthogonal safeguards. Martin RM; Fowler JL; Cromer MK; Lesch BJ; Ponce E; Uchida N; Nishimura T; Porteus MH; Loh KM Nat Commun; 2020 Jun; 11(1):2713. PubMed ID: 32483127 [TBL] [Abstract][Full Text] [Related]
14. Intact wound repair activity of human mesenchymal stem cells after YM155 mediated selective ablation of undifferentiated human embryonic stem cells. Kim KT; Jeong HC; Kim CY; Kim EY; Heo SH; Cho SJ; Hong KS; Cha HJ J Dermatol Sci; 2017 May; 86(2):123-131. PubMed ID: 28185769 [TBL] [Abstract][Full Text] [Related]
15. Prediction of Differentiation Tendency Toward Hepatocytes from Gene Expression in Undifferentiated Human Pluripotent Stem Cells. Yanagihara K; Liu Y; Kanie K; Takayama K; Kokunugi M; Hirata M; Fukuda T; Suga M; Nikawa H; Mizuguchi H; Kato R; Furue MK Stem Cells Dev; 2016 Dec; 25(24):1884-1897. PubMed ID: 27733097 [TBL] [Abstract][Full Text] [Related]
16. Technical approaches to induce selective cell death of pluripotent stem cells. Jeong HC; Cho SJ; Lee MO; Cha HJ Cell Mol Life Sci; 2017 Jul; 74(14):2601-2611. PubMed ID: 28246701 [TBL] [Abstract][Full Text] [Related]
17. Dynamic suspension culture for scalable expansion of undifferentiated human pluripotent stem cells. Amit M; Laevsky I; Miropolsky Y; Shariki K; Peri M; Itskovitz-Eldor J Nat Protoc; 2011 May; 6(5):572-9. PubMed ID: 21527915 [TBL] [Abstract][Full Text] [Related]
18. Modulating cell state to enhance suspension expansion of human pluripotent stem cells. Lipsitz YY; Woodford C; Yin T; Hanna JH; Zandstra PW Proc Natl Acad Sci U S A; 2018 Jun; 115(25):6369-6374. PubMed ID: 29866848 [TBL] [Abstract][Full Text] [Related]
19. Controlled Growth and the Maintenance of Human Pluripotent Stem Cells by Cultivation with Defined Medium on Extracellular Matrix-Coated Micropatterned Dishes. Takenaka C; Miyajima H; Yoda Y; Imazato H; Yamamoto T; Gomi S; Ohshima Y; Kagawa K; Sasaki T; Kawamata S PLoS One; 2015; 10(6):e0129855. PubMed ID: 26115194 [TBL] [Abstract][Full Text] [Related]
20. Exploring the effects of cell seeding density on the differentiation of human pluripotent stem cells to brain microvascular endothelial cells. Wilson HK; Canfield SG; Hjortness MK; Palecek SP; Shusta EV Fluids Barriers CNS; 2015 May; 12():13. PubMed ID: 25994964 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]